Consistent with literature that CYGB is epigenetically downregulated in several types of malignancies [12, 13, 25, 30–32], we detected CYGB down-regulation associated with promoter hypermethylation in breast cancer cell lines and tissues. The gene discussed is CYGB; the disease is breast cancer.